We are live on ! Find out more
69.46 USD
+0.85
1.24%
At close Updated Oct 2, 1:33 PM EDT
1 day
1.24%
5 days
1.7%
1 month
-6.41%
3 months
3.66%
6 months
27.71%
Year to date
16.06%
1 year
43.1%
5 years
-22.96%
10 years
23.84%
 

About: Ashland Inc. is a specialty materials company serving markets including pharmaceuticals, personal care, food and beverages, coatings, construction, energy, and electronics. It operates through four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences contributes the highest revenue, offering functional additives for pharmaceutical and nutrition applications. Personal Care provides ingredients for skin, hair, oral care, and household products, while Specialty Additives supplies performance-enhancing additives for coatings and. Intermediates produce BDO and related derivatives used in polymers, electronics, agriculture, and pharmaceutical applications. The company generates sales across North America, Europe, Asia Pacific, Latin America, and regions.

Employees: 2,900

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 33.3%
Neutral 61.9%
Negative 4.8%
Positive
Zacks Investment Research
3 days ago
ASH's Shares Rally 30% in 6 Months: What's Driving the Upside?
Ashland's shares have gained 30.2% in six months as cost cuts, portfolio optimization and a $1-billion buyback support returns.
ASH's Shares Rally 30% in 6 Months: What's Driving the Upside?
Neutral
GlobeNewsWire
10 days ago
Ashland scales Transformed Vegetable Oils technology platform in crop care, launches agrimer™ eco-disperse OD polymeric dispersant
WILMINGTON, Del., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Continuing to scale its Transformed Vegetable Oils (TVO™) technology platform, Ashland Inc. (NYSE: ASH), today announced the global launch of agrimer™ eco-disperse OD TVO™ polymeric dispersant, a patented, nature-based dispersant developed for non-aqueous crop protection formulations.
Ashland scales Transformed Vegetable Oils technology platform in crop care, launches agrimer™ eco-disperse OD polymeric dispersant
Neutral
Seeking Alpha
14 days ago
Ashland Inc. (ASH) Analyst/Investor Day Transcript
Ashland Inc. (ASH) Analyst/Investor Day Transcript
Ashland Inc. (ASH) Analyst/Investor Day Transcript
Positive
Zacks Investment Research
16 days ago
Here's Why You Should Retain ASH Stock in Your Portfolio Now
Ashland is using cost savings, portfolio optimization and buybacks to strengthen margins and free cash flow despite tariff and demand headwinds.
Here's Why You Should Retain ASH Stock in Your Portfolio Now
Neutral
GlobeNewsWire
18 days ago
Ashland Innovation Day to be held September 17, 2026
Wilmington, Del., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) will host an Innovation Day webcast on September 17, 2026.
Ashland Innovation Day to be held September 17, 2026
Neutral
GlobeNewsWire
1 month ago
Ashland to host Innovation Day for analysts and investors
Wilmington, Del., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) will host a live Innovation Day webcast for analysts and investors from Wilmington, Delaware on September 17, 2026. The event will provide an updated view of Ashland's Technology Platforms, including their commercial progress and scalability.  Registration is required and can be accessed from the following link: innovationday26.ashland.com
Ashland to host Innovation Day for analysts and investors
Positive
Zacks Investment Research
1 month ago
Ashland (ASH) Up 2% Since Last Earnings Report: Can It Continue?
Ashland (ASH) reported earnings 30 days ago. What's next for the stock?
Ashland (ASH) Up 2% Since Last Earnings Report: Can It Continue?
Neutral
Zacks Investment Research
1 month ago
ASH Launches Permexa Sodium Caprate to Support Oral Biologics Growth
Ashland launches Permexa sodium caprate to support oral peptide and biologic development with enhanced processing and permeability.
ASH Launches Permexa Sodium Caprate to Support Oral Biologics Growth
Neutral
GlobeNewsWire
1 month ago
Ashland advances high-growth oral biologics delivery applications with launch of permexa™ sodium caprate
WILMINGTON, Del., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH), is announcing the launch of permexa™ sodium caprate, a high-performance intestinal permeation enhancer designed to support the scalable development and commercialization of oral peptide, biologic and low-permeability drug products, including rapidly expanding GLP-1 agonists and related therapeutic pipelines.
Ashland advances high-growth oral biologics delivery applications with launch of permexa™ sodium caprate
Positive
Seeking Alpha
1 month ago
Ashland Inc.: Activist Pressure Starts To Pay Off
Ashland Inc. (ASH) remains a Buy, with the investment case now centered on activist-driven M&A potential and strategic alternatives. Life Sciences and Personal Care segments, comprising 82% of gross EBITDA, continue to deliver growth and margin stability, underpinning valuation. Multiple activist investors, including Standard Industries and Ancora, have driven board changes, capital allocation reviews, and engagement with potential acquirers.
Ashland Inc.: Activist Pressure Starts To Pay Off
Price charts implemented using Lightweight Charts™